Advertisement

Submit Manuscripts
Author Information
Subscribe/Renew
Order Reprints
Email Alerts
Feedback
RSS Feed
CME

About the Journal
Editorial Board & Staff

About JACC CME
Hardware/Software Requirements
Contact Us
Policy on Privacy and Confidentiality
Copyright Information

JACC Imaging Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?
Click here
to sign up now!

ACC.org
Cardiosmart
Cardiosource
CVN
Imaging Library
JACC Imaging
JACC Interventions

Click here for more guidelines.
2009 Focused Updates: ACC/AHA Guidelines for STEMI and ACC/AHA/SCAI Guidelines for PCI
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
ACC 2009 Advocacy Position Statement: Principles for Comparative Effectiveness Research
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2007; 49:1924-1930, doi:10.1016/j.jacc.2007.01.081 (Published online 30 April 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (43)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menichelli, M.
Right arrow Articles by Violini, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Menichelli, M.
Right arrow Articles by Violini, R.
Related Collections
Right arrowRelated Article

Randomized Trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI)

Maurizio Menichelli, MD*,*, Antonio Parma, MD*, Edoardo Pucci, MD*, Rosario Fiorilli, MD*, Francesco De Felice, MD*, Marco Nazzaro, MD*, Alessia Giulivi, MD*, Domenico Alborino, MD*, Arianna Azzellino, PhD{dagger} and Roberto Violini, MD*

* Division of Interventional Cardiology, San Camillo Hospital, Rome, Italy
{dagger} Politecnico Milano, Milan, Italy.


Figure 1
View larger version (17K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 1 CONSORT Diagram of the Study

BMS = bare-metal stents; CONSORT = Consolidated Standards of Reporting Trials; SES = sirolimus-eluting stents.

 

Figure 2
View larger version (34K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 2 Actuarial Rate of Survival Free From TLR and TVF Among Patients Who Received an SES or a BMS

The rate of event-free survival was significantly higher in the sirolimus-eluting stent (SES) group. BMS = bare-metal stent; TLR = target lesion revascularization; TVF = target vessel failure.

 
 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement